T1	Participants 43 121	patients with heart failure due to reduced left ventricular systolic function.
T2	Participants 244 335	patients with heart failure (HF) due to reduced left ventricular ejection fraction (HFREF).
T3	Participants 418 435	those with HFREF.
T4	Participants 498 526	patients with heart failure.
T5	Participants 628 653	2331 patients with HFREF.
T6	Participants 654 778	Patients with New York Heart Association class II to IV HF and left ventricular ejection fractions of â‰¤ 35% were recruited
T7	Participants 888 941	as baseline Hb <13 g/dL and <12 g/dL in men and women
T8	Participants 1191 1311	in 1763 subjects (76% of total study population); their median age was 59.0 years, 73% were male, and 62% were Caucasian
T9	Participants 2874 2904	in patients with chronic HFREF
